Department of Orthopaedics, Southern California Permanente Medical Group, San Diego, California.
Surgical Outcomes and Analysis, Kaiser Permanente, San Diego, California.
J Bone Joint Surg Am. 2021 Nov 3;103(21):2032-2044. doi: 10.2106/JBJS.20.02110.
Although safety in same-day discharge total joint arthroplasty (TJA) has been reported, findings are limited to healthier patients, specific surgeons, and/or specific institutions. Indications for same-day discharge TJA have expanded to include patients with multiple comorbidities; however, safety in this specific patient population remains unknown. Therefore, we sought to compare the risk of 90-day adverse events in higher-risk patients undergoing same-day discharge versus inpatient TJA.
The Kaiser Permanente Total Joint Replacement Registry was utilized to conduct a cohort study. All patients with an American Society of Anesthesiologists (ASA) classification of ≥3 who underwent primary elective TJA for osteoarthritis from 2017 through 2018 were identified. The risk of 90-day adverse events (i.e., emergency department visits, unplanned readmissions, complications, and mortality) was evaluated with use of propensity score-weighted Cox proportional hazard regression including noninferiority testing with a margin of 1.10.
The cohort included a total of 5,250 patients who underwent total hip arthroplasty and 9,752 patients who underwent total knee arthroplasty, of whom 1,742 (33.2%) and 3,283 (33.7%) had same-day discharge, respectively. Same-day discharge hip arthroplasty was noninferior to an inpatient stay in terms of emergency department visits (hazard ratio [HR], 0.73; 1-sided HR 95% upper bound [UB], 0.84), readmissions (HR, 0.47; 95% UB, 0.61), and complications (HR, 0.63; 95% UB, 0.75); we did not have evidence of noninferiority for mortality (HR, 0.84; 95% UB, 1.97). Same-day discharge knee arthroplasty was noninferior to an inpatient stay in terms of emergency department visits (HR, 0.79; 95% UB, 0.87), readmission (HR, 0.80; 95% UB, 0.95), complications (HR, 0.72; 95% UB, 0.82), and mortality (HR, 0.53; 95% UB, 1.03).
We found that same-day discharge TJA did not increase the risk of emergency department visits, unplanned readmissions, and complications compared with an inpatient stay for higher-risk patients, suggesting that it is possible to expand indications for same-day discharge TJA in the hospital setting while maintaining safety.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
虽然当日出院全关节置换术(TJA)的安全性已有报道,但这些发现仅限于更健康的患者、特定的外科医生和/或特定的机构。当日出院 TJA 的适应证已扩展到包括患有多种合并症的患者;然而,这一特定患者群体的安全性仍不清楚。因此,我们旨在比较高风险患者行当日出院与住院 TJA 的 90 天不良事件风险。
利用 Kaiser Permanente 全关节置换登记处进行了一项队列研究。从 2017 年至 2018 年,我们确定了所有接受择期初次 TJA 治疗骨关节炎且美国麻醉医师协会(ASA)分级≥3 的患者。使用倾向评分加权 Cox 比例风险回归评估 90 天不良事件(即急诊就诊、非计划再入院、并发症和死亡率)的风险,并进行非劣效性检验,置信区间为 1.10。
该队列包括 5250 例全髋关节置换术患者和 9752 例全膝关节置换术患者,其中 1742 例(33.2%)和 3283 例(33.7%)行当日出院。当日出院髋关节置换术在急诊就诊(风险比[HR],0.73;单侧 HR 95%上限[UB],0.84)、再入院(HR,0.47;95%UB,0.61)和并发症(HR,0.63;95%UB,0.75)方面不劣于住院治疗;我们没有证据表明死亡率不劣于(HR,0.84;95%UB,1.97)。当日出院膝关节置换术在急诊就诊(HR,0.79;95%UB,0.87)、再入院(HR,0.80;95%UB,0.95)、并发症(HR,0.72;95%UB,0.82)和死亡率(HR,0.53;95%UB,1.03)方面不劣于住院治疗。
我们发现,对于高风险患者,与住院治疗相比,当日出院 TJA 并不会增加急诊就诊、非计划再入院和并发症的风险,这表明在维持安全性的同时,有可能扩大当日出院 TJA 的适应证。
治疗性 III 级。请参阅作者说明以获取完整的证据水平描述。